More $NTLA News: Our EVP, Chief Operating Officer, Andrew Schiermeier, Ph.D., will be joining the new company as President and CEO. Thank you, Andrew, for your great leadership and helping Intellia grow to what it is today. Best of luck in your new role! #celltherapy #CRISPR https://t.co/ZqHWc9mSbx